B. Zhang et al. / Steroids 77 (2012) 1086–1091
1087
Fig. 1. 7b-Nitromethyl-4,5-dihydrocanrenone; 7b-nitromethyl-D9(11)-4,5-dihydrocanrenone and 6b,7b-methylene-(10S)-nitro-3-oxo-17
a-pregn-4-en-21-carboxylic acid, c-
lactone.
were run on Bruker AM-300, Bruker AM-400 spectrometer using
tetramethyl silane as the internal standard (d = 0). Splitting pat-
terns were designated as ‘‘s, d, t, q, and m’’; these symbols indicated
‘‘singlet, doublet, triplet, quartet, and multiplet’’, respectively. X-ray
crystallographic data were obtained on a CAD-4 diffractometer.
Optical rotations were recorded on a Jasco-Dip-181 polarimeter.
Mass spectra and high-resolution mass spectra were measured on
a Finnigan MAT-95 mass spectrometer. High performance liquid
chromatograms (HPLC) were taken on Agilent 1100 instruments
1274, 1192; UVmax: 242 nm; 1H NMR (300 MHz,CDCl3) d5.82 (s,
1H), 4.38–4.20 (m, 2H), 4.10 (tt, J = 10.29, 10.29, 4.95, 4.95 Hz,
1H), 2.81 (td, J = 13.99, 4.16, 4.16 Hz, 1H), 2.73–2.27 (m, 10H),
2.07–1.70 (m, 7H), 1.68–1.59 (m, 2H), 1.50 (ddd, J = 24.57, 12.19,
5.69 Hz, 1H), 1.38 (s, 3H), 1.04 (s, 3H); 13C NMR(100 MHz,CDCl3)
d 199.092, 176.239, 164.980, 128.330, 94.707, 74.029, 68.710,
53.387, 46.162, 45.170, 43.219, 39.867, 37.704, 37.471, 36.477,
35.951, 35.328, 34.207, 31.127, 29.087, 22.276, 18.343, 15.679; EI
MS(70 eV, m/z): 417(M+, 21%), 399(17%), 370(44%), 111(100%);
HR-MS(EI) calcd for C23H31NO6(M+) 417.2151, Found 417.2153;
Anal. Calc. for C23H31NO6: C, 66.17; H, 7.48; N, 3.35. Found: C,
66.35; H, 7.63; N, 3.31%.
and Waters 2998 with column Venusii MP™ C18, 5
lm, 100 Å,
10 ꢁ 250 mm and SunFine™ C18, 5 m,4.6 ꢁ 150 mm. Silica gel
l
60 H (200–300 mesh) manufactured by Qingdao Haiyang Chemical
Co. (China) was generally used for chromatography. N,N-dimethyl
formamide (DMF) and MeNO2 were distilled and dried by 4 Å
molecular sieves overnight. K2CO3 was well ground into a powder,
baked at 145 °C for 10 h and then cooled in desiccator with P2O5.
TMG, TEA and DIPEA were short for trimethylglycine, triethyl amine
and N,N-Diisopropylethylamine, respectively. The purity of each
step product was >98%, which was determined by HPLC and H NMR.
Compound 5b: 1H NMR (300 MHz,CDCl3) d 5.73 (s, 1H), 4.73 (dd,
J = 12.72, 3.72 Hz, 1H), 4.37 (dd, J = 12.51, 7.64 Hz, 1H), 4.15–3.99
(m, 1H), 2.67–1.37 (m, 21H), 1.35 (s, 3H), 1.03 (s, 3H); 13C
NMR(100 MHz,CDCl3) d199.556, 176.137, 166.179, 125.006,
93.623, 80.058, 68.297, 58.043, 47.763, 47.027, 43.126, 41.537,
39.625, 38.306, 37.275, 37.004, 35.457, 34.181, 30.969, 29.052,
26.114, 18.600, 16.023; UVmax
z):417(M+, 17%), 111(100%), 370(37%); HR-MS(EI) calcd for
23H31NO6(M+) 417.2151, found 417.2157.
: 243 nm; EI MS(70 eV, m/
C
2.1. 11 b,17b-Dihydroxy-7
a
/b-nitromethyl-pregna-4-en-3-one-21-
and b)
carboxylic acid, -lactone (5
c
a
2.2. 11 b,17b-dihydroxy-7a-nitromethyl-pregna-4-en-3-one-21-
To a solution of compound 4 (1.07 g, 3 mmol) in MeNO2 (10 ml),
1,8-Diazabicyclo [5.4.0] undec-7-ene (DBU) (0.8 ml, 5.3 mmol) was
added at room temperature and stirred overnight. The resulting
reaction was quenched by a.q. HCl (10% w/w) to adjust the pH to
6. Then solvent was removed under vacuum and the residue was
purified by silica column chromatography eluted with EtOAc/
carboxylic acid, -lactone (5a)
c
To a solution of compound 4 (20 g, 56 mmol), octadecyl di-
methyl benzyl ammonium chloride (2.32 g, 6 mmol) and MeNO2
(60 ml, 1120 mmol) in DMF (190 ml) equipped with a CaCl2 drying
tube and a reflux condenser, K2CO3 (78 g, 565 mmol) was added at
90 °C with stirring. The mixture was stirred at this temperature for
48 h. The resulting mixture was cooled to room temperature, and
then filtered. The filter cake was washed with dichloride methane
(DCM) for three times. The organic layers were combined with the
filtrate, and adjusted pH to 6 with a.q. HCl (10%, w/w). The HPLC
cyclohexane (1:4, v/v) to afford diastereomers 5
yield) and b (192 mg, 15% yield). The compound 5
recrystallized from EtOAc to afford colorless crystals.Compound
: mp:281–282 °C; [ ]20D: 51° (c 0.24, CHCl3); IR max(KBr)
3467, 2950, 1766, 1662, 1550, 1458, 1441, 1419, 1382, 1344,
a
(308 mg, 25%
a
was readily
5a
a
m
Scheme 1. Synthesis of 5a and its application in synthesis Eplerenone 8.